This
adran has no associated
Memorandwm Esboniadol
157. In regulation 203 (amendment of regulation 260 (package leaflets))—U.K.
(a)in paragraph (2), in the inserted paragraph (1A), after the first reference to “advanced therapy medicinal product” insert “ for sale or supply in Great Britain only ”;
(b)in paragraph (3), in the inserted text, after “advanced therapy medicinal product,” insert “ for sale or supply in Great Britain only ”;
(c)in paragraph (4)—
(i)omit “, Article 126a authorisation”;
(ii)after “UK marketing authorisation” insert “ , EU marketing authorisation, ”.
Commencement Information
I1Sch. 2 para. 157 in force at 31.12.2020 immediately before IP completion day, see reg. 1